Skip to main content

Table 2 Local reactions after autologous E.coli autovaccine

From: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

Subject

Erythema

Induration

Local pain*

Itch

No. 1

V32 →

V32 →

V32 →

-

No. 2

V16 →

-

-

-

No. 3

V22 →

V23 →

V22

-

No. 4

V25 →

V25 →

-

-

No. 5

V29 →

V29 →

-

-

No. 6

V26 →

V26 →

-

V26 →

No. 7

V22 →

V22 →

V22

V31 →

No. 8

V13 →

V13 →

-

V8/16/25; V27 →

No. 9

V9 →

V9 →

V17 →-

V9

episodes total No. (per 306 injections)

101 (33%)

95 (31%)

27 (8.8%)

30 (9.8%)

episodes/subject [median No., range]

12 (1-26)

10 (0-25)

n.a.

n.a.

average size [cm, range]

2.5 (2-11)

3.0 (0-11)

n.a.

n.a.

  1. V32 → = after visit 32 and every following visit; V22 = after visit 22; * = mild in character; n.a. = not applicable